BackCymabay Therapeutics Overview

Cymabay Therapeutics Cost of Revenue

Cost of Revenue analysis for CBAY.

Quarterly Cost of Revenue

$56000.00
↓ 69.73% YoY

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$681000.00
↑ 25.88% YoY

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin